Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation.
Woldesellassie M BezabheLuke R BereznickiJan RadfordBarbara C WimmerColin CurtainMohammed S SalahudeenGregory M PetersonPublished in: European journal of clinical investigation (2020)
The proportion of newly diagnosed patients with AF initiated on OAC increased markedly following the introduction of the DOACs. Of those initiated, 9 in 10 were receiving a DOAC at the end of the study period. There is potential underuse in women and individuals with dementia.
Keyphrases
- newly diagnosed
- atrial fibrillation
- direct oral anticoagulants
- venous thromboembolism
- end stage renal disease
- mild cognitive impairment
- oral anticoagulants
- left atrial
- polycystic ovary syndrome
- left atrial appendage
- cognitive impairment
- chronic kidney disease
- peritoneal dialysis
- metabolic syndrome
- risk assessment
- climate change
- acute coronary syndrome